Šalis: Pietų Afrika
kalba: anglų
Šaltinis: South African Health Products Regulatory Authority (SAHPRA)
Roussel
SOFRA-TULLE SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): SOFRA-TULLE COMPOSITION: Framycetin Sulphate BP 10 mg per gram of base PHARMACOLOGICAL CLASSIFICATION: A. 14.2 Wound Dressings PHARMACOLOGICAL ACTION: Soframycin (framycetin sulphate), a broad spectrum antibiotic, will control and eradicate most secondary infections which may be present in the lesion and at the same time will provide an excellent mechanical protection which does not adhere to granulating skin. It is easy to apply and may be removed painlessly. Application of the dressing does not result in maceration of the lesion. INDICATIONS: Traumatic: Lacerations, abrasions, grazes (gravel rash), bites (animal and insect), cuts, puncture wounds, crush injuries, surgical wounds and incisions, traumatic ulcers. Ulcerative: Varicose ulcers, diabetic ulcers, bed-sores, tropical ulcers. Thermal: Burns, scalds. Elective: Skin grafts (donor and recipient sites), avulsion of finger or toe-nails, circumcision. Miscellaneous: Secondary infected skin conditions, e.g. eczema, dermatitis, herpes zoster, colostomy, acute paronychia, incised abscesses (packing), ingrowing toe-nails. CONTRA-INDICATIONS: Allergy to lanolin or to Soframycin. DOSAGE AND DIRECTION FOR USE: If necessary, the wound may first be cleaned. Following this a single Sofra-tulle dressing should be applied directly to the wound and covered with an appropriate dressing. In the case of ulcers it is advisable to cut the dressing exactly to the size of the ulcer and not to overlap onto the surrounding epidermis. When the lesion is very exudative it is advisable to change the dressing at least once day, otherwise it may be left in situfor 2 - 3 days. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: I Perskaitykite visą dokumentą